secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2026-08-03T12:37:46+00:00
Accession:  0001193125-26-329622
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Curium to acquire Lantheus for up to $114.50/share ($8.0B); 38% premium to 60-day VWAP
--------------------------------------------------------------------------------

- Total consideration up to $114.50/share: $102.50 cash at closing plus up to $12.00 in CVRs tied to commercial milestones through 2030.
- Aggregate transaction value up to $8.0B; premiums of 38% (60-day VWAP), 29% (30-day VWAP), and 21% (unaffected close).
- Lantheus Board unanimously approved; transaction expected to close in first half of 2027, subject to shareholder and regulatory approvals.
- Lantheus pauses CEO search, suspends FY2026 guidance, and will not host Q2 2026 earnings call due to pending merger.
- Combined company will serve oncology, neurology, and cardiology patients across more than 70 countries.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000119312526329622/0001193125-26-329622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000119312526329622/d148563d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-329622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer